论文部分内容阅读
目的分析老年肺结核患者行胸腺肽α1联合抗结核药物治疗的临床效果。方法 120例老年肺结核患者,按照不同治疗方案分为研究组(66例)与对照组(54例)。对照组采用常规抗结核药物治疗,研究组在对照组治疗基础上采用胸腺肽α1治疗,观察并比较两组疗效及不良反应。结果研究组治疗总有效率(92.42%)显著高于对照组(74.07%),差异有统计学意义(P<0.05)。两组不良反应比较差异无统计学意义(P>0.05)。结论老年肺结核患者采用胸腺肽α1与抗结核药物联合治疗临床效果显著,值得借鉴应用。
Objective To analyze the clinical effect of thymosin α1 combined with anti-tuberculosis drugs in elder patients with pulmonary tuberculosis. Methods A total of 120 elderly pulmonary tuberculosis patients were divided into study group (66 cases) and control group (54 cases) according to different treatment plans. The control group was treated with conventional antituberculosis drugs. The study group was treated with thymosin α1 on the basis of the control group. The curative effect and adverse reactions of the two groups were observed and compared. Results The total effective rate of study group (92.42%) was significantly higher than that of control group (74.07%), the difference was statistically significant (P <0.05). There was no significant difference in adverse reactions between the two groups (P> 0.05). Conclusion Elderly patients with tuberculosis thymosin α1 and anti-tuberculosis drugs combined treatment of significant clinical effect, it is worth learning from.